Company profile: Inova
1.1 - Company Overview
Company description
- Provider of digital partnering solutions for the biopharma and life sciences industry, offering Inpart, a platform connecting academic researchers, universities and industry to facilitate collaboration and commercialization; Connect, an algorithm- and machine learning–based matchmaking platform aligning biotech assets with biopharma needs; Deal, a CRM for biopharma partnering; and Event, software for managing in-person or online life science conferences and meetings.
Products and services
- Connect: A machine learning-powered online matchmaking platform that uses algorithms to match biotech assets with biopharma based on predefined needs and requirements, enabling precise, need-driven partnering
- Deal: A biopharma-specific CRM that centralizes partnering data, streamlines collaboration, and enhances reporting and compliance to manage biopharma partnering
- Inpart: A comprehensive platform for scientific partnering that connects academic researchers, universities, and industry professionals to facilitate collaboration and commercialization of research across life sciences
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Inova
Metagenomi
HQ: United States
Website
- Description: Provider of an AI- and metagenomics-driven discovery platform to uncover novel genome editing systems for therapeutics development and a comprehensive gene editing toolbox, including programmable nucleases, base editors, RNA- and DNA-mediated integration systems, ultra-small systems deliverable via single AAV for organ targeting, and RNA Mediated Integration Systems for small and large programmable genomic edits.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Metagenomi company profile →
Formation Bio
HQ: United States
Website
- Description: Provider of a drug development platform and AI-driven tools to accelerate and optimize clinical trials and drug discovery. Offerings include an end-to-end platform leveraging proprietary technology, a clinical trial engine to improve recruitment, data collection and monitoring, and a universal data platform centralizing clinical data for rapid application creation and trial design.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Formation Bio company profile →
Progeny Genetics
HQ: United States
Website
- Description: Provider of genotype management and laboratory information management software for leading biomedical concerns in 80+ countries. Offers configurable sample inventory, barcoding, custom workflows, and chain-of-custody tracking, plus clinical tools for family history, pedigree drawing, risk assessment, genetic test ordering, high-risk triage, and EMR integration.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Progeny Genetics company profile →
123Compliance
HQ: United States
Website
- Description: Provider of compliance-focused solutions for the life science industry, with more than 20 years of experience. As a Salesforce partner, has built and implemented global complaint handling, quality management, regulatory reporting, and document management systems for small and large pharmaceutical and medical device companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 123Compliance company profile →
FlowJo
HQ: United States
Website
- Description: Provider of life sciences software for flow cytometry and single-cell analysis, offering FlowJo for viewing and analyzing flow cytometric data (sample management, gating, statistics, graphical layouts), BD Research Cloud for secure cloud storage, sharing and collaboration with integration to analysis software, and SeqGeq for single-cell RNA sequencing (scRNA-seq) data analysis and visualization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full FlowJo company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Inova
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Inova
2.2 - Growth funds investing in similar companies to Inova
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Inova
4.2 - Public trading comparable groups for Inova
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →